(PR NewsChannel) / August 8, 2017 / CHICAGO
FH Orthopedics, Inc. (FH Inc.), a designer and manufacturer of sports medicine, trauma and joint reconstruction products, announced today the successful first total shoulder arthroplasty using the novel Arrow®Prime cementless glenoid baseplate. Supported by 14 years of successful clinical history, Arrow®Prime offers surgeons unparalleled intraoperative flexibility, dual-platform interchangeability, and addresses the continuum of indications for shoulder arthroplasty in an efficient, 4-tray instrument system.
The Arrow®Prime was cleared by the FDA in April 2017 and has been implanted successfully in multiple centers across the U.S.
Patrick Noud, MD (Lansing, MI) implanted the first Arrow®Prime cementless glenoid baseplate in the U.S. “My initial experience was very satisfying. Relative to traditional cemented polyethylene glenoid implants, the Arrow®Prime anatomic metal-backed glenoid and instrumentation were seamless and efficient, the press-fit of the porous implant impressive, and the procedure was quicker, as no bone cement was required.”
